טוען...
Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI
Background and Aims: Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. We investigated, in a highly translatable animal m...
שמור ב:
Main Authors: | , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Frontiers Media S.A.
2022-05-01
|
סדרה: | Frontiers in Pharmacology |
נושאים: | |
גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fphar.2022.891801/full |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|